LAUSANNE, Switzerland – Sophia Genetics, the global leader in Data Driven Medicine (DDM), today announced the closing of a new $15 million Series C financing round led by Omega founder and healthcare scion Marc Coucke. The funds will be used to continue Sophia’s rapid market expansion and broaden its range of genomic tests. Witnessing a […]
BEIJING & SAN DIEGO — Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc. (NASDAQ: ILMN) today announced they have entered into an agreement to jointly develop advanced clinical applications in the fields of reproductive health and oncology based on next-generation sequencing (NGS) technology. The collaboration signals the increasing importance of […]
MARCY L’ETOILE, France & SAN DIEGO — bioMérieux, a world leader in the field of in vitrodiagnostics, and Illumina (Nasdaq: ILMN), a world leader in genomics, announce the launch of bioMérieux EpiSeqTM, an innovative next-generation sequencing (NGS) service dedicated to the epidemiological monitoring and control of healthcare-associated infections. The bioMérieux EpiSeqTM service is the first […]
Beijing & San Diego — Novogene, a leading global provider of genomic services and solutions, and Illumina, Inc. (NASDAQ: ILMN) announced they have entered into an agreement to jointly develop advanced clinical applications in the fields of reproductive health and oncology based on next-generation sequencing (NGS) technology. The collaboration signals the increasing importance of genomic […]
Oxford and Cambridge, UK – Oxford Gene Technology (OGT), the molecular genetics company, has continued its impressive sales performance and has refocused its business to take advantage of the significant growth potential in the global genomics market. Commercial and financial highlights for the year ended 30 September show the company delivering £14.3m sales revenues on […]
SAN FRANCISCO — Illumina, Inc. (NASDAQ:ILMN) announced today that Illumina Accelerator–the world’s first business accelerator focused solely on creating an innovation ecosystem for the genomics industry–has selected four new investments from a competitive pool of highly qualified applicants to be a part of its third funding cycle. “Illumina Accelerator is pleased to have such a […]
BALTIMORE, MD – University of Maryland (UM) Ventures and Pataigin, LLC, announced today that the University of Maryland, Baltimore (UMB) has granted Pataigin worldwide, exclusive licensing rights to UMB patents and technology to develop a method to quickly and accurately identify dangerous pathogens. Robert Ernst, Ph.D., associate professor of microbial pathogenesis at University of Maryland […]
BILLERICA, Mass. —— RainDance Technologies, Inc., a genomics tools company dedicated to simplifying the analysis of complex genetic diseases, and Blood Systems Research Institute (BSRI) today announced a research collaboration to develop blood-based assays and protocols for the precise measurement of the human immunodeficiency virus (HIV) latent reservoir using RainDance’s RainDrop® Digital PCR and ThunderBolts™ […]
ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced the PDX NGS Gateway Program, a service designed to enable partner personalized medicine initiatives. PierianDx CEO Ted Briscoe said the NGS Gateway Program was developed in direct response to feedback from customers based on the growth of personalized medicine efforts across the country. […]
SomaLogic, Inc., announced that its SomaLogic Clinical Laboratory (CLIA laboratory) has been registered with the Centers for Medicare and Medicaid Services (CMS) under the Clinical Laboratory Improvement Amendments of 1988, and has received accreditation by the College of American Pathologists (CAP). “The CAP accreditation of our CLIA laboratory is an important milestone on our way […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
